Cleveland Biolabs' (CBLI) CBLB502 gets fast track status from FDA
Tweet Send to a FriendGet Alerts CBLI Hot Sheet
Up)
Trade CBLI Now!
Cleveland Biolabs' (Nasdaq: CBLI) CBLB502 gets fast track status from FDA
You May Also Be Interested In
- Cardiovascular Systems (CSII) ORBIT II Trial Met Endpoints
- Merck (MRK) Says Efficacy Not Achieved in Preladenant Phase 3s; Will Discontinue
- Tessera (TSRA), Starboard Reach Agreement Over Board Composition
Create E-mail Alert Related Categories
Corporate News, FDA, Hot List
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
